Conditions: Major Depressive Disorder
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 529
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate the efficacy, safety, and tolerability of vilazodone relative to placebo in adolescent outpatients (12-17) with major depressive disorder.

Detailed description:

Arms:
arm 1: Dose-matched placebo tablets, once per day, oral administration arm 2: 15 mg vilazodone tablets, once per day, oral administration arm 3: 30 mg vilazodone tablets, once per day, oral administration

Interventions: intervention 1: Placebo intervention 2: Vilazodone intervention 3: Vilazodone
Intervention descriptions: intervention 1: Dose matched placebo tablets, once per day, oral administration. intervention 2: Vilazodone tablets, 15 mg per day, oral administration intervention 3: Vilazodone tablets, 30 mg once per day, oral administration

Protocol document: